Expression of the p53 homologue p630 alpha and Delta Np63 alpha in normal and neoplastic cells

Citation
Pa. Hall et al., Expression of the p53 homologue p630 alpha and Delta Np63 alpha in normal and neoplastic cells, CARCINOGENE, 21(2), 2000, pp. 153-160
Citations number
53
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CARCINOGENESIS
ISSN journal
01433334 → ACNP
Volume
21
Issue
2
Year of publication
2000
Pages
153 - 160
Database
ISI
SICI code
0143-3334(200002)21:2<153:EOTPHP>2.0.ZU;2-2
Abstract
A burgeoning family of p53-related genes have been described recently, incl uding p73 and p63, Both these genes encode proteins with many similarities to p53 but also with the potential for forming a range of related species b y alternative promoter usage and alternative splicing. In order to begin th e characterization of p63, we generated a polyclonal serum (designated SC1) that recognizes the C-terminus of p63 alpha. We have shown that this reage nt recognizes p63 alpha but not p53 nor p73, By western blot analysis both p63 alpha and the N-terminal truncated form of p63 alpha (Delta Np63 alpha) were found in a range of cell lines. Similar immunoblot analysis of tissue s reveals considerable complexity with at least four SC1-immunoreactive iso forms being identified. In immunohistological studies SC1 immunoreactivity is widely detectable, being predominantly associated with proliferative com partments in epithelia. However, non-proliferative populations can also sho w SC1 immunostaining, No simple relationship between the isoforms identifie d by immunoblotting of tissue lysates and the tissue immunostaining charact eristics was identified. A previously unrecognized species intermediate in mobility between p63 alpha and Delta Np63 alpha was found in several tissue s, including nerve and peripheral blood lymphocytes, Interestingly, there i s suppression of p63 alpha expression in HaCat cells in a time- and concent ration-dependent manner after UV and MMS treatment. Our data provide furthe r information about the complexity of p63 and the SC1 serum will prove to b e a useful tool in further studies of this p53 homologue.